PhD (2012) in Pharmacy (Toxicology), Universidade de Lisboa
Post-Doctoral Fellow, iMed.ULisboa, Faculdade de Farmácia, Universidade de Lisboa
Faculdade de Farmácia, Universidade de Lisboa — Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
Vasco Branco’s research concerns how the interaction between mercury compounds and antioxidant systems (thioredoxin; glutathione) modulates the unfolding of neurodevelopmental toxicity. Namely, the research is focused on understanding how mercury affects microglia activation and neural stem cell differentiation. Knowledge of these early toxic events is a key tool for identifying potential biomarkers of early effect to be used in Human Risk Assessment. How selenium compounds interact with mercurials and modify toxicity is also an interest.
Branco V, Coppo L, Solá S, Lu J, Rodrigues CMP, Holmgren A, Carvalho C. Impaired cross-talk between the thioredoxin and glutathione systems is related to ASK-1 mediated apoptosis in neuronal cells exposed to mercury. Redox Biol 2017; 13: 278-287.
Ren X, Zou L, Zhang X, Branco V, Wang J, Carvalho, C, Holmgren A, Lu J. Thioredoxin and Glutathione Systems Mediated Redox Signaling in Central Nervous System. Antioxid Redox Sign 2017; 13: 278-287
Branco V, Caito S, Farina M, Rocha JBT, Aschner M, Carvalho C. Biomarkers of Mercury Toxicity: Past, Present and Future Trends. J Toxicol Environ Health B 2017; 20: 119-154.
Branco V, Godinho-Santos A, Gonçalves J, Lu J, Holmgren A, Carvalho C. Mitochondrial thioredoxin reductase inhibition, selenium status and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds. Free Radic Biol Med 2014; 73: 95-105.
Branco V, Canário J, Lu J, Holmgren A, Carvalho C. Mercury and selenium interaction in vivo: effects on thioredoxin reductase and glutathione peroxidase. Free Radic Biol Med 2012; 52: 781-793.